시장 개관

The global market for minimally invasive spine technologies exhibited a value of $3,181 백만 단위 2022, with expectations to reach $9,407 백만 단위로 2032. This represents a compound annual growth rate (CAGR) ~의 11.45% 예측 기간 동안 2022 에게 2032. The growth in this market can be attributed to the increasing preference for minimally invasive spine surgical procedures on a global scale, as well as the growing awareness among practitioners regarding simulation, training, and continuous medical education.

Minimally invasive spine surgery (MISS) has gained significant popularity in recent years due to advancements in surgical techniques and technologies. The primary objective of MISS is to minimize surgical-related injuries and preserve normal anatomy while achieving comparable surgical outcomes to traditional open procedures. 따라서, patients who undergo MISS often experience fewer adverse effects during and after surgery, shorter surgical times, and quicker returns to work, leading to improved quality of life. The continuous technological advancements in surgical systems and instruments have brought about groundbreaking changes in the healthcare landscape worldwide. Minimally invasive spine technology has successfully permeated various surgical fields. The evolution of technologies, coupled with advancements in computing, has enhanced surgeons’ skills, resulting in higher accuracy in complex surgical procedures. 추가적으로, the market has witnessed increased competition among key players in terms of patents.

게다가, the implementation of lockdowns and travel restrictions during the pandemic led to delays in procuring raw materials and delivering them to end users.

The following factors drive the demand for minimally invasive spine technologies:
Increasing incidences and prevalence of spinal disorders.
Rising preference for minimally invasive spine surgeries.
Technological advancements in minimally invasive spine surgical procedures.

하지만, the market is expected to face certain limitations due to the following challenges:
Lack of a well-established landscape for reimbursement of minimally invasive spinal procedures.
High costs associated with capital equipment purchases and disposables.
Shortage of skilled professionals resulting from a lack of training.

시장 세분화

시장은 다양한 요인에 따라 분류됩니다., including Condition, 최종 사용자, 및 지역.

Segmentation by Condition
Herniated Disc
Spinal Stenosis
Degenerative Disc Disease
Spinal Deformity
Spinal Fracture
Spinal Infection
Spinal Tumor

최종 사용자별 세분화
병원
Ambulatory Surgery Centers
Orthopedic Clinics

지역별 세분화
북아메리카 – 우리를. 캐나다
유럽 – 독일, 프랑스, 영국, 이탈리아, 스페인, 및 유럽 나머지 지역
아시아 태평양 – 일본, 중국, 인도, 호주, 대한민국, 및 기타 아시아 태평양 지역
라틴 아메리카 – 브라질, 멕시코, 및 나머지 라틴 아메리카
중동 및 아프리카 – 남아프리카, 아랍에미리트, 및 기타 중동 및 아프리카

The degenerative disc disease segment dominated the global minimally invasive spine technologies market in 2021, with a value of $819 백만, followed by the herniated disc segment at $662 백만. Degenerative disc disease is a natural consequence of aging, where the intervertebral discs become less elastic, flexible, and shock-absorbing. It can also be caused by back injuries. Lumbar degenerative spine disease (DSD) is a common condition characterized by various clinical symptoms, including lower extremity discomfort, weakness, and low back pain (LBP) of varying severity, which significantly impacts quality of life. The incidence of spinal disorders, including degenerative spinal disorders and lower back pain, has been increasing globally. A study published in Sage Journals estimated that 266 million individuals worldwide had degenerative spinal disorders and LBP. 결과적으로, there has been a growing adoption of minimally invasive spine surgery for the treatment of degenerative spinal diseases. Research suggests that in certain cases, minimally invasive spine surgery (MISS) is preferred over traditional open techniques.

The hospitals segment accounted for a significant share in the global minimally invasive spine technologies market, 도달하다 $1,967 백만 단위 2021, 도달할 것으로 예상됩니다. $6,142 백만 단위로 2032, CAGR로 10.86% 예측 기간 동안 2022-2032. Hospitals are the primary purchasers of minimally invasive spine surgery products due to factors such as the increasing elderly population suffering from age-related spine disorders, rising prevalence of spinal disorders, preference for minimally invasive procedures, and technological advancements in minimally invasive spine technology. The demand for spine surgical robotic technologies from healthcare providers is also contributing to the growth in this segment. Private hospitals that can afford the cost-intensive robotic surgical systems and have the resources for surgeon training are leading the adoption of these minimally invasive spine procedures. 하지만, there is a shift towards reducing healthcare costs by moving inpatient procedures to outpatient centers, impacting the purchasing patterns of hospitals.

North America held the largest market share of 50.74% ~에 2021, followed by Europe at 21.65%. The Asia Pacific region is expected to experience significant growth, CAGR로 12.66% 예측 기간 동안 2022-2032. North America and Europe have advanced healthcare systems and allocate substantial budgets to healthcare, making them key players in the global minimally invasive spine technologies market. The Asia Pacific, 라틴 아메리카, and Middle East and Africa regions are anticipated to witness substantial growth due to increasing preference for minimally invasive surgeries, a rising geriatric population, and the demand to streamline surgical workflows.

North America is the dominant market for minimally invasive spine technologies and is projected to maintain its dominance in the future, CAGR로 성장 10.95% 예측 기간 동안 2022-2032. The region boasts technologically advanced healthcare systems and a concentration of established manufacturers in the minimally invasive spine technologies market. The United States and Canada comprise the North America region, which serves as the hub of innovation in this field globally. 추가적으로, North America leads in the adoption of minimally invasive spine technologies.

경쟁 구도

The selection of profiled companies is based on inputs collected from primary experts, as well as an analysis of company coverage, 제품 포트폴리오, 그리고 시장 침투.

Key companies profiled in this report include AMS Group, Alphatec Holdings, 주식회사, Aurora Spine, 주식회사, 비. Braun SE, 보스턴 사이언티픽 코퍼레이션, Globus Medical, 주식회사, 존슨 & 존슨, 메드트로닉 PLC, NuVasive, 주식회사, ORTHOFIX MEDICAL INC., Precision Spine, 주식회사, Richard Wolf GmbH, Spineart, Spineology Inc., Stryker Corporation.

최근 산업 발전

6월 2022, NuVasive, 주식회사. inaugurated its Singapore Experience Center in the Asia-Pacific region to facilitate the company’s growth and expand its global presence.

4월 2022, SeaSpine introduced the Reef TA (TLIF Articulating) Interbody System. This innovative system is designed to precisely deliver an interbody to the anterior part of the spinal disc space, aiming to improve sagittal alignment and provide enhanced support to the endplate. With a range of footprint and lordotic options, the Reef TA Interbody System offers surgeons flexibility in addressing specific anatomical requirements during surgical procedures.

10 월 2022, Orthofix and SeaSpine merged on equal terms to establish a leading global company in the spine and orthopedics industry.

7월 2022, Medtronic plc obtained approval from the U.S. Food and Drug Administration (FDA) for the latest version of its UNiD Spine Analyzer, which incorporates a predictive model for degenerative spinal surgery.

10 월 2022, Captiva Spine formed an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics, aiming to expand their product portfolio.

주요 질문에 대한 답변

What are the primary market drivers, 도전, and opportunities in the global market for minimally invasive spine technologies?

What are the emerging trends in the global market for minimally invasive spine technologies?

What is the growth potential of the global market for minimally invasive spine technologies in North America, 유럽, 아시아 태평양, 라틴 아메리카, and the Middle East and Africa?

What is the trend in patent filings within the global market for minimally invasive spine technologies?

What are some of the ongoing clinical trials in the global market for minimally invasive spine technologies?

How is the market segmented based on different conditions in the global market for minimally invasive spine technologies?

How has the COVID-19 pandemic impacted the global market for minimally invasive spine technologies?